BioCentury
ARTICLE | Financial News

SutroVax raises $85M, names Slaoui chair

June 7, 2018 9:42 PM UTC

SutroVax Inc. (South San Francisco, Calif.) raised $85 million in an oversubscribed series C round led by new investor TPG on a newsy Thursday that also saw the vaccine company appoint Moncef Slaoui chairman and sign a deal with contract manufacturing organization Lonza Group Ltd. (SIX:LONN).

Fellow new investors Medicxi and Foresite participated as did all existing investors including Abingworth, Longitude Capital, Frazier Healthcare Partners, Pivotal bioVenture Partners, Roche Venture Fund and CTI Life Sciences Fund...

BCIQ Company Profiles

Pfizer Inc.

Vaxcyte Inc.